Stocktoria
Viking Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,026,131 | $319.4M | 5.25% |
| TWO SIGMA INVESTMENTS, LP | 3,937,414 | $153.6M | 3.43% |
| CITADEL ADVISORS LLC | 2,676,815 | $104.4M | 2.33% |
| D. E. Shaw & Co., Inc. | 1,680,894 | $65.6M | 1.46% |
| MILLENNIUM MANAGEMENT LLC | 514,872 | $20.1M | 0.45% |
| Point72 Asset Management, L.P. | 508,608 | $19.8M | 0.44% |
| AQR CAPITAL MANAGEMENT LLC | 200,958 | $7.8M | 0.18% |
| Bridgewater Associates, LP | 87,859 | $3.4M | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.